Strides Arcolab Update by Epic Research

Strides Arcolab has partnered with Gilead Sciences Inc whereby the latter has licensed Strides to produce generic sofos uvir and investigational single tablet regimen of ledipasvir/sofosb uvir for treatment of chronic Hepatitis C, for distribution to 91 developing countries including India, Eqypt & Indonesia which are high burden countries.



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips